BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21842605)

  • 1. [Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome].
    Saito T
    Nihon Jinzo Gakkai Shi; 2011; 53(5):708-12. PubMed ID: 21842605
    [No Abstract]   [Full Text] [Related]  

  • 2. [Membranous nephropathy].
    Yuzawa Y; Hasegawa M; Nabeshima K
    Nihon Jinzo Gakkai Shi; 2010; 52(7):894-8. PubMed ID: 21077337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines for the treatment of nephrotic syndrome].
    Japanese Society of Nephrology
    Nihon Jinzo Gakkai Shi; 2011; 53(2):78-122. PubMed ID: 21516692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Refractory nephrotic syndrome].
    Saito T
    Nihon Rinsho; 2004 Oct; 62(10):1794-9. PubMed ID: 15500120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic membranous nephropathy: new therapeutic trends.
    Rostoker G
    Eur J Med; 1993 Feb; 2(2):106-16. PubMed ID: 8258013
    [No Abstract]   [Full Text] [Related]  

  • 7. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC; Sethi S; Specks U
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy: when and how to treat.
    Lai KN
    Kidney Int; 2007 May; 71(9):841-3. PubMed ID: 17457329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of membranous glomerulonephritis: analysis of data from the Italian Renal Biopsy Registry].
    Garozzo M; Puliatti D; Battaglia GG
    G Ital Nefrol; 2011; 28(4):425-30. PubMed ID: 21809312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
    Muñoz Díaz AB; Aguilar P
    Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
    Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. III. Rapidly progressing glomerulonephritis and the use of converting enzyme inhibitors and non-steroidal anti-inflammatory drugs in idiopathic nephrotic syndrome].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(11):779-83. PubMed ID: 2623185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines for the treatment of childhood IgA nephropathy].
    Yoshikawa N; Igarashi T; Ishikura K; Kaku Y; Nakazato H; Kamei K; Kawamura T; Nakamura H; Yamamoto Y; Nakanishi K; Sako M
    Nihon Jinzo Gakkai Shi; 2008; 50(1):31-41. PubMed ID: 18318242
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
    Johnston PA; Goode NP; Aparicio SR; Davison AM
    Transplantation; 1993 Jan; 55(1):214-6. PubMed ID: 8420053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
    Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.